EUROPEAN RESEARCH ORGANISATION ON GENITAL INFECT..
EUROGIN 2021May 30 - June 1, 2021 Virtual Conference
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| P27-001 | SerologicaL HPV tumor marker DRH1 shows high sensitivity and specificity for anal dysplasia in people living with HIV | Anna Huber |  Received |
 |
|||
| P31-001 | Real world evidence answering questions about human papillomavirus vaccines effectiveness to prevent genital warts and its relationship with the immunological status in women 14-23 y/o | Mónica López-Lacort | Received |
|
|||
| P09-001 | Colposcopy, cervical and cone biopsy: the casuistic after implementation of a population screening program | Inês Margarida Gomes | Received |
|
|||
| P40-001 | A prospective cohort study of cervical dysplasia and time-to-pregnancy | Mette L. Kristensen | Received |
|
|||
| P24-001 | Review of predicting factors for an hemmorhagic LLETZ procedure in a representative sample | Georgios Michail | Received |
|
|||
| P10-001 | Preference and acceptance of HPV self-sampling: gaining insights on urine as a sample type | David Faster | Received |
|
|||
| P07-001 | Efficacy of a coriolus versicolor-based multi-ingredient vaginal gel in HPV women older than 40 years: sub-analysis of paloma clinical trial | Javier Cortés | Received |
|
|||
| P06-001 | Final Phase 2 Trial Efficacy Results at 6 months after the last Administration of VGX-3100 for the Treatment of HPV16 and/or HPV-18 (HPV16/18) related Anal HSIL | Pankti Bhatt | Received |
|
|||
| P14-001 | Current screening tests for cervical cancer detection: review, evidence, and further recommendations | Victor Manuel Vargas-Hernández | Received |
|
|||
| P29-001 | Human papillomavirus (HPV) in adenoid cystic carcinoma (ACC) of the head and neck region reveals three cases of HPV related carcinoma with ACC like features | Mark Zupancic | Received |
|
|||
| P02-001 | Incidence of HPV and HPV related dysplasia in elderly women in Sweden | Annika Lindstrm | Received |
|
|||
| P22-001 | Evaluation of managing CIN 3-diagnosed pregnant women by methylation assessment using the QIASURE methylation test | Monika Hampl | Received |
|
|||
| P25-001 | CIN2 diagnoses between 2013 and 2018 in women 18 to 45 years old an analysis of German statutory health insurance claims data | Monika Hampl | Received |
|
|||
| P12-001 | Analytical validation of the Onclarity HPV assay for self-collected specimens | Millie Shah | Received |
|
|||
| P13-001 | Exploring cervical HR-HPV genotypes among asymptomatic women in Grenada, West Indies | Ronelle Bailey | Received |
|
|||
| P35-001 | Healthcare related costs during 24 months follow-up of patients undergoing cervical conization a retrospective study of German statutory health insurance claims data | Kunal Saxena | Received |
|
|||
| P18-001 | Vaginal microbiota and human papillomavirus (HPV) infection among young Swedish women | Andreas hrlund-Richter | Received |
|
|||
| P08-001 | MSWAB medium, a non-alcohol-based media for eluting dry self-collected vaginal swabs for hpv detection with commercial assays | Santina Castriciano | Received |
|
|||
| P36-001 | Parental knowledge of HPV and vaccine acceptability in Spain: results from Kappas survey | Noelia López Malpartida | Received |
|
|||
| P08-002 | Cross-platform high-risk (hr) low occurrence HPV NAAT positive samples for use in nucleic acid detection testing as prospective external quality assessment samples and user defined quality controls | Pavel Zhelev | Received |
|
|||
| P13-002 | Human papillomavirus genotype attribution in Wielkopolska region (Poland) retrospective study | Dominik Pruski | Received |
|
|||
| P29-002 | Antitumor effects in vitro of FGFR and PI3K inhibitors on HPV positive and HPV negative tonsillar and base of tongue cancer cell lines | Ourania kostopoulou | Received |
|
|||
| P35-002 | Disease burden of cervical and head and neck cancers in Taiwan: a population-based database analysis | Lily Wu | Received |
|
|||
| P12-002 | Post-collection stability of human papillomavirus DNA in first-void urine | Vanessa Vankerckhoven | Received |
|
|||
| P09-002 | Opportunistic diagnosis of cervical high-grade squamous intraepithelial lesion in a woman with perianal warts | Elisa Soares | Received |
|
|||
| P25-002 | The new classification of cervical adenocarcinoma - correlation with histological features and molecular markers | Mihai Mitran | Received |
|
|||
| P09-003 | Prevalences of STI and HPV in a womens prison in the state capital of São Paulo | Marco Zonta | Received |
|
|||
| P35-003 | Modelling the impact of using a DNA vs mRNA HPV assay as part of the cervical screening programmes in Sweden and Denmark | Caroline Dombrowski | Received |
|
|||
| P13-003 | HPV16 sublineages related with preinvasive lesions and invasive cervical cancer in Venezuelan women | ENRIQUE JOSE ALVIREZ FREITES | Received |
|
|||
| P12-003 | Feedback from a colposcopy referral population on the use of Colli-pee for HPV-based cervical cancer screening (CASUS) | Koen Beyers | Received |
|
|||
| P08-003 | Clinical significance of HC2 test borderline results in Slovenian cervical cancer screening program ZORA | Jerneja Varl | Received |
|
|||
| P08-004 | Five-year cumulative incidence of CIN2 for women with HPV triage test in Slovenian organized cervical cancer screening program ZORA | Veronika Kloboves Prevodnik | Received |
|
|||
| P12-004 | Validation of Floqswabs for cervical and vaginal physician specimen collection and patients vaginal self-collected specimens analyzed with the Femoflor screen and HPV quant quantitative real-time PCR assays | Anastasiia Kunashova | Received |
|
|||
| P35-004 | Evaluating the choice of HPV assay for a proposed French cervical screening programme using a health economic model | Caroline Dombrowski | Received |
|
|||
| P13-004 | Human papillomavirus genotype distribution in a primary screening population in spain | Juan Manuel Peñate Garrido | Received |
|
|||
| P35-005 | Evaluating the benefits and costs of using an mRNA versus DNA hrHPV assay in the national cervical screening programme in The Netherlands | Caroline Dombrowski | Received |
|
|||
| P35-006 | Estimating the costs and benefits of HR-HPV assay choice in a theoretical HPV primary cervical screening algorithm in Ontario, Canada | Caroline Dombrowski | Received |
|
|||
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 30/04/2021 TO 30/05/2022
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
|
|
